F783-0017 Screening compound: N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

F783-0017 Screening compound: N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide
F783-0017 Screening compound: N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F783-0017
N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F783-0017

Molecular Formula

C25H23ClN4O2 (C25 H23 ClN4 O2)

Compound Name

N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-1,3-benzodiazole-5-carboxamide

IUPAC name

N-[(2-chlorophenyl)methyl]-2-[(4-propanamidophenyl)methyl]-1H-13-benzodiazole-5-carboxamide

SMILES

CCC(Nc1ccc(Cc2nc(cc(cc3)C(NCc(cccc4)c4Cl)=O)c3[nH]2)cc1)=O

InChI

InChI=1S/C25H23ClN4O2/c1-2-24(31)28-19-10-7-16(8-11-19)13-23-29-21-12-9-17(14-22(21)30-23)25(32)27-15-18-5-3-4-6-20(18)26/h3-12,14H,2,13,15H2,1H3,(H,27,32)(H,28,31)(H,29,30)

InChI Key

PRUJJXASMKMTIM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14966683

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

446.94

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.804

Distribution Coefficient, logD

4.803

Water Solubility, LogSw

-4.92

Polar Surface Area

67.811

Acid Dissociation Constant (pKa)

10.78

Base Dissociation Constant (pKb)

4.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.00

F783-0017 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

GPCR Targeted Library (31838 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Chemokine Receptor-Targeted Library (18382 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Immune system
Targets:
  • GPCR
  • Proteases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F783-0017 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F783-0017?
Check Price and Availability of F783-0017, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F783-0017 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F783-0017
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F783-0017
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F783-0017 available by request